P/ 310-827-7707 | F/ 310-574-4002 | MAIL@PROSTATEONCOLOGY.COM
Cancer spreading just outside the capsule of the gland or into the seminal vesicles with otherwise clear scans is termed locally advanced. Modern radiation can effectively control locally advanced cancer when the cancer is confined to the region immediately surrounding the prostate. However, since microscopic metastases may be present, radiation to the pelvic lymph nodes should be discussed. When pelvic radiation is administered, testosterone inactivation pharmaceuticals (TIP) should be added.
Fears about the existence of microscopic metastasis should never be the basis for the decision to forgo treatment to the prostate. Rather, an aggressive approach using every potential means to eradicate the cancer is indicated.
MARINA DEL REY, Calif., May 6, 2019 /PRNewswire/ — PROSTATE PROS is a new monthly podcast hosted by prostate cancer specialist and author Mark Scholz, MD. Beginning June 03, 2019, …
BY MARK SCHOLZ, MD Selecting treatment for prostate cancer is complex. Start by taking the Staging Quiz (keytopc.com). This is the first-step to understanding proper management. Once you know your …
BY MARK SCHOLZ, MD Hormones play a large role in cancer growth. They are also integral to treatment. Testosterone is a key player. It originates mostly in the testicles and, …
BY MARK SCHOLZ, MD What Is the Best Therapy for Me? This is one of the greatest questions for men with prostate cancer. How do you arrive at a reliable …
BY MARK SCHOLZ, MD Unhealthy diets encourage prostate cancer’s growth and spread. Consider Asia, where mortality from prostate cancer is eighteen times lower than in the United States. Genetic factors …
When I was 10 years old, my mother lost a close friend to cancer. I was too young to know anything about serious illness, but when I asked her why …
BY MARK SCHOLZ, MD Being diagnosed with cancer often stimulates people into action and triggers powerful survival instincts. Numerous purveyors of alternative medicine cater to these natural fears, and in …
BY MARK SCHOLZ, MD I have cared for prostate cancer patients for more than 20 years. Patients come to me with all kinds of wrong notions. Here are 10 of …
BY MARK SCHOLZ, MD Every year, 200,000 men are diagnosed with prostate cancer. Confusion about optimal treatment is widespread. The doctors even defer to their patients saying, “Since it’s about …
BY MARK SCHOLZ, MD Axumin is an FDA-approved, Medicare-covered scan that can achieve early detection of recurrent prostate cancer after surgery or radiation. For years we have been able to …